SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: July 31, 2001
PATHOBIOTEK DIAGNOSTICS INC.
----------------------------
(Exact name of registrant as specified in its charter post-merger)
Texas 000-28519 76-0510754
- --------------------- ---------- -----------------
(State or other (Commission File No.) (IRS Employer
jurisdiction of Identification No.)
incorporation)
4800 Research Forest Drive, The Woodlands, TX 77381-4142
--------------------------------------------------------
(New Address)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE (281) 364-6054
--------------
ITEM 1. CHANGES IN CONTROL OF REGISTRANT
None.
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS
At a shareholder's meeting held on July 16, 2001, the shareholders
approved:
a. Transfer of Technology, patents, and proprietary research to Pathobiotek
Inc. a wholly owned subsidiary.
b. Spin-off by dividend, share for share (pre-reverse split), of the
subsidiary Pathobiotek Inc. to shareholders, pro rata, effective for
shareholders as of record date of meeting June 22, 2001.
ITEM 3. BANKRUPTCY OR RECEIVERSHIP
None.
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
None.
ITEM 5. OTHER EVENTS
At a shareholder's meeting held on July 16, 2001, the shareholders
approved:
A one for forty reverse split of common shares except no shareholder to be
reduced to less than 10 shares.
ITEM 6. RESIGNATION AND APPOINTMENT OF DIRECTORS
None.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIALS, & EXHIBITS
Exhibits: None.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: August 6, 2001 Pathobiotek Diagnostics Inc.
/s/ Robert C. Simpson
By: -----------------------------------
Robert C. Simpson, President
3